Oct 30 2024
A new study from Colombia’s Universidad de Antioquia, published in the peer reviewed journal Medical Cannabis and Cannabinoids, highlights CBD-rich oil as a treatment option for neuropsychiatric symptoms (NPS) in Alzheimer’s disease (AD). In a two-year prospective study, researchers observed that a majority of patients experienced significant improvements in symptoms and a reduction in caregiver …
Oct 30 2024
A study published in the peer reviewed journal Medical Cannabis and Cannabinoid and e-published by the National Library of Medicine reveals promising findings on the impact of high-THC marijuana on PTSD symptoms. The real-world, observational study examined 58 UK civilians who had prior cannabis experience and a confirmed PTSD diagnosis, with data sourced from the …
Oct 29 2024
A new study highlights the potential of cannabis-derived compounds as effective agents against multidrug-resistant (MDR) bacterial infections. The study is being published in the upcoming issue of the European Journal of Microbiology and Immunology, and it was published online ahead of print by the U.S. National Library of Medicine. “The number of human infections with …
Oct 29 2024
A study, published in Molecular Psychiatry, led by Professor Bernard Lerer from the Department of Psychiatry at the Hadassah—Hebrew University Medical Center shows promising results for using psilocybin as a potential treatment for obsessive-compulsive disorder (OCD) and Tourette’s syndrome. The study, titled “Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the …
Oct 28 2024
Researchers from Lebanese American University and Germany’s University of Veterinary Medicine Hannover have published findings in the journal Scientific Reports indicating that cannabinoids derived from Lebanese cannabis may offer significant anti-cancer properties. Specifically, their study explored how CBD and THC mixtures influence the growth and motility of breast cancer cells in vitro. The research team …
Oct 26 2024
In a new study, researchers have identified high-CBD extract (CBD-X) as a potential game-changer for asthma treatment, especially for patients who find little relief from conventional inhaled corticosteroids. Published in the Journal of Pharmaceuticals, the study reveals how CBD-X could disrupt key inflammatory pathways driving asthma’s chronic symptoms, potentially offering fresh hope to millions worldwide …
Oct 25 2024
Researchers at São Paulo State University have demonstrated that cannabis extracts containing cannabidiol (CBD) and tetrahydrocannabinol (THC) can inhibit the growth of canine prostate carcinoma cell lines, potentially offering new avenues for cancer treatment. Published in Veterinary Sciences, the study states that prostate cancer “is one of the leading causes of cancer-related deaths worldwide, even …
Oct 25 2024
A new study has found that cannabidiol (CBD) may help alleviate behavioral and neuroinflammatory challenges in adult offspring born to obese mothers. “Maternal obesity is known to increase the risk of psychiatric disorders, such as anxiety, depression, schizophrenia and autism spectrum disorder in the offspring”, notes the study’s abstract. “While preventive measures are well-documented, practical approaches …
Oct 25 2024
A recent study published in Pediatric Reports by researchers from Florida Atlantic University provides a comprehensive look into the evolving patterns of marijuana use among U.S. adolescents over the past decade. Using data from the biennial Youth Risk Behavior Survey from 2011 to 2021, which covered 88,183 students in grades 9 through 12, the study …
Oct 24 2024
A recent observational study published in the Journal of Pain & Palliative Care Pharmacotherapy suggests that patients with fibromyalgia (FM) experience significant symptom improvement when using cannabis-based medicinal products (CBMPs). Conducted by researchers from Imperial College London and Kings College London, the study followed 148 patients enrolled in the UK Medical Cannabis Registry who used …
